Drug intelligence / Profile preview

Relaxation Active Study Product 3.1

Development stage: Preclinical
Lead developer: Radicle Science
Administration: Oral

Overview

Relaxation Active Study Product 3.1 is a dietary supplement under investigation in a randomized, double-blind, placebo-controlled clinical trial evaluating its effects on stress and related health outcomes in adults. The product is one of several "Relaxation Active Study Products" assessed for their ability to reduce perceived stress, anxiety, and emotional distress, and to improve cognitive function. The precise formulation and mechanism of action are not disclosed in the available study documentation. The primary developer and sponsor is Radicle Science[1][2][3][4].

Brand names: Relaxation Active Study Product 3.1
Other names: Relaxation Active Study Product 3.1

Beyond the preview

Go deeper on Relaxation Active Study Product 3.1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relaxation Active Study Product 3.1.

Explore the full profile